Supplementation of fibrin gels with sodium chloride enhances physical properties and ensuing osteogenic response
Source abstract
Abstract
Modifying the relative concentrations of fibrinogen and thrombin can control the physical properties of fibrin gels, while the viability of associated cells has been linked to the gel's final network structure. It was hypothesized that increasing the gel ionic strength during fabrication through supplementation with sodium chloride (NaCl) would provide an improved approach for tailoring the physical properties of fibrin gels and maintaining the viability and osteogenic potential of entrapped cells. Fibrin gels were formed by mixing fibrinogen, thrombin and calcium chloride with varying masses of NaCl (0-4.40% w/v), and the osteogenic potential of entrapped human mesenchymal stem cells (MSC) was examined over 14 days. Physical properties including gelation time, compressive modulus and fiber diameter were dependent upon NaCl content, with gels containing 2.60% NaCl possessing compressive moduli threefold higher than gels without NaCl. Alkaline phosphatase activity was highest for MSC entrapped in gels containing 2.15-2.60% NaCl after 14 days, and all gels exhibited increased calcium incorporation over the culture period. These data confirm that varying the salt concentration of the pre-gel solution can modulate the material properties of fibrin constructs without additional fibrinogen or thrombin, thereby offering a new approach for generating improved cell transplantation vehicles for use in bone tissue regeneration.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Blood properties and coagulation · Periodontal Regeneration and Treatments · Mesenchymal stem cell research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (45)
Show source-provided references
1. Tissue engineering – current challenges and expanding opportunities10.1126/science.1069210 ↗
2. Biomaterials in tissue engineering10.1038/nbt0695-565 ↗
3. Fibrin as a delivery system for therapeutic drugs and biomolecules10.1089/ten.teb.2008.0527 ↗
4. Role of fibrin matrix in angiogenesis10.1111/j.1749-6632.2001.tb03526.x ↗
5. Fibrin as an alternative biopolymer to type-1 collagen for the fabrication of a media equivalent10.1002/jbm.10107 ↗
6. Fibrin: A versatile scaffold for tissue engineering applications10.1089/ten.teb.2007.0435 ↗
7. Comparative kinetics of polymerisation of three fibrin sealants and influence on timing of tissue adhesion10.1016/S0049-3848(99)00234-0 ↗
8. Recent clinical and investigational applications of fibrin sealant in selected surgical specialties10.1016/j.jamcollsurg.2005.11.027 ↗
9. A comparison of fibrin sealants in relation to their in vitro and in vivo properties10.1016/j.thromres.2003.10.010 ↗
10. Fabrication and physical and biological properties of fibrin gel derived from human plasma10.1088/1748-6041/3/1/015001 ↗
11. A biodegradable fibrin scaffold for mesenchymal stem cell transplantation10.1016/S0142-9612(02)00618-X ↗
12. The behavior of human mesenchymal stem cells in 3D fibrin clots: dependence on fibrinogen concentration and clot structure10.1089/ten.2006.12.1587 ↗
13. Influence of thrombin concentration on the mechanical and morphological properties of cell-seeded fibrin hydrogels10.1016/j.actbio.2006.08.006 ↗
14. Progressive cross-linking of fibrin gamma chains increases resistance to fibrinolysis10.1016/S0021-9258(18)46943-8 ↗
15. Discrete crosslinked fibrin microthread scaffolds for tissue regeneration10.1002/jbm.a.31057 ↗
16. Controlled compaction with ruthenium-catalyzed photochemical cross-linking of fibrin-based engineered connective tissue10.1016/j.biomaterials.2009.08.039 ↗
17. Increase of fibrin gel elasticity by enzymes: a kinetic approach10.1016/j.actbio.2009.08.001 ↗
18. New method to prepare autologous fibrin glue on demand10.1016/j.trsl.2006.08.004 ↗
19. Fibrinopeptides and fibnin gel structure10.1016/j.bpc.2004.07.013 ↗
20. Calculation of plasma fibrin fiber mass-length ratios utilizing platelet aggregometers10.1016/0049-3848(90)90283-I ↗
21. Mass-length ratio of fibrin fibers from gel-permeation and light-scattering10.1002/bip.1977.360160102 ↗
22. Influence of Ca2+ on the structure of reptilase-derived and thrombin-derived fibrin gels10.1042/bj2390513 ↗
23. Calcium and fibrin gel structure10.1016/0049-3848(83)90039-7 ↗
24. Factors influencing fibrin gel structure studied by flow measurement10.1111/j.1749-6632.1983.tb23248.x ↗
25. Osteogenesis and trophic factor secretion are influenced by the composition of hydroxyapatite/poly(lactide-co-glycolide) composite scaffolds10.1089/ten.tea.2009.0255 ↗
26. Mesenchymal cells stimulate capillary morphogenesis via distinct proteolytic mechanisms10.1016/j.yexcr.2010.01.013 ↗
27. The behavior of human mesenchymal stem cells in 3D fibrin clots: dependence on fibrinogen concentration and clot structure10.1089/ten.2006.12.1587 ↗
28. Modulation of 3D fibrin matrix stiffness by intrinsic fibrinogen-thrombin compositions and by extrinsic cellular activity10.1089/ten.tea.2008.0319 ↗
29. Human mesenchymal stem cell proliferation and osteogenic differentiation in fibrin gels in vitro10.1089/ten.2006.12.2385 ↗
30. Oxygen tension differentially influences osteogenic differentiation of human adipose stem cells in 2D and 3D cultures10.1002/jcb.22514 ↗
31. Biomimetic scaffolds fabricated from apatite-coated polymer microspheres10.1002/jbm.a.32169 ↗
32. Identification of a fibrin-independent platelet contractile mechanism regulating primary hemostasis and thrombus growth10.1182/blood-2007-12-127001 ↗
33. Mechanical properties of actin stress fibers in living cells10.1529/biophysj.108.133462 ↗
34. Preparation and properties of serum and plasma proteins. 8: the conversion of human fibrinogen to fibrin under various conditions10.1021/ja01194a066 ↗
35. Important factors influencing the strength of autologous fibrin glue; the fibrin concentration and reaction time – comparison of strength with commercial fibrin glue10.1159/000129346 ↗
36. Fibrin clot formation and lysis: basic mechanisms10.1055/s-2000-13216 ↗
37. Fibrin gel structure and clotting time10.1016/0049-3848(82)90214-6 ↗
38. Cl− regulates the structure of the fibrin clot10.1016/S0006-3495(98)77638-6 ↗
39. Release of fibrinopeptides by the slow and fast forms of thrombin10.1021/bi952834d ↗
40. Thrombin-cofactor interactions – structural insights into regulatory mechanisms10.1161/01.ATV.0000228844.65168.d1 ↗
41. Long-term stable fibrin gels for cartilage engineering10.1016/j.biomaterials.2006.08.027 ↗
42. Kinetics of fibrinopeptide release by thrombin as a function of CaCl2 concentration: different susceptibility of FPA and FPB and evidence for a fibrinogen isoform-specific effect at physiological Ca2+ concentration10.1021/bi034411e ↗
43. Native fibrin gel networks observed by 3D microscopy, permeation and turbidity10.1016/0167-4838(89)90140-4 ↗
44. Fibrin in human plasma: gel architectures governed by rate and nature of fibrinogen activation10.1016/0049-3848(94)90227-5 ↗
45. Structural origins of fibrin clot rheology10.1016/S0006-3495(99)77113-4 ↗